H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 6.4% of adults in Ann Arbor have diagnosed diabetes — 5.6 points below the U.S. 12% figure. Census population 123,851. Michigan Medicare wound biologics: WPS Government Health Administrators (J8). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Ann Arbor clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Ann Arbor storefront.
Fibrin Matrix Therapy Products in Ann Arbor, MI for clinics & physicians. Fibrin matrix therapy supports w… Compliance support & pricing — contact Hawk Medical.
6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 6.4% of adults in Ann Arbor have diagnosed diabetes — 5.6 points below the U.S. 12% figure. Population 123,851. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and J8 documentation are ready before the first application of fibrin matrix therapy.
National Fibrin Matrix Therapy Products notes (how the product actually works)6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city under 250k with 123,851 residents will still mix those payers. CDC PLACES (2023, crude) estimates 6.4% of adults in Ann Arbor have diagnosed diabetes — 5.6 points below the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 6.4% of adults in Ann Arbor have diagnosed diabetes — 5.6 points below the U.S. 12% figure. Adult arthritis here is 16.7% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Ann Arbor.
CDC PLACES (2023, crude prevalence) estimates 6.4% of adults — 5.6 points below the U.S. 12% figure. Obesity is 25.8%; arthritis is 16.7%. That is place-level BRFSS modeling, not a clinic census and not a Ann Arbor trial.
Start with the CDC National Diabetes Statistics Report and America's Health Rankings diabetes measure (BRFSS). Michigan Department of Health & Human Services is the state public-health home. Those are the citable sources — not this page’s city name in a headline.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
CDC estimates 12% of the U.S. population has diabetes (40.1 million people, 2023). America's Health Rankings (BRFSS 2024) shows state adult rates from Colorado 8.4% to West Virginia 18.4%. We do not publish a made-up city diabetes count. Use national/state published rates plus your panel.
Bring specialty, monthly wound volume, and whether you bill J8 FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 6.4% diabetes and 16.7% arthritis for Ann Arbor — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Ann Arbor, MI.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Ann Arbor is J8 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Ann Arbor — 5.6 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Michigan Part B wound biologics follow this contractor (siblings: IN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Ann Arbor. Useful for joint-program math; still needs a diagnosis and privileging.
No Ann Arbor storefront. Joe Bradley is an active practice owner. fibrin matrix therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.